Bcl-2 and Bcl-X(L) serve an anti-inflammatory function in endothelial cells through inhibition of NF-κB

Journal of Clinical Investigation

Volumn 103, Issue 4, 1999, Pages 543-553

  Badrichani, A Z ^a   Stroka, D M ^a   Bilbao, G ^b   Curiel, D T ^b   Bach, F H ^a   Ferran, Christiane ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CATTLE; CELL PROTECTION; ENDOTHELIUM CELL; GENE MAPPING; GENE OVEREXPRESSION; NONHUMAN; PRIORITY JOURNAL;

EID: 0033557372     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2517     Document Type: Article

References (86)

1. Pober, J.S., et al. 1990. The potential roles of vascular endothelium in immune reactions [review]. Hum. Immunol. 28:258-262.
2. Cotran, R.S., and Pober, J.S. 1990. Cytokine-endothelial interactions in inflammation, immunity, and vascular injury. J. Am. Soc. Nephrol. 1:225-235.
3. Bach, F.H., et al. 1994. Endothelial cell activation and thromboregulation during xenograft rejection [review]. Immunol. Rev. 141:5-30.
4. Gimbrone, M.A.J. 1995. Vascular endothelium: an integrator of pathophysiologic stimuli in atherosclerosis [review]. Am. J. Cardiol. 75:67B-70B.
5. Read, M.A., Whitley, M.Z., Williams, A.J., and Collins, T. 1994. NF-κB and IκBα - an inducible regulatory system in endothelial activation. J. Exp. Med. 179:503-512.
6. Collins, T., et al. 1995. Transcriptional regulation of endothelial cell adhesion molecules - NF-κB and cytokine-incucible enhancers. FASEB J. 9:899-909.
7. Bach, F.H., et al. 1997. Accommodation of vascularized xenografts: expression of "protective genes" by donor endethelial cells in a host Th2 cytokine environment. Nat. Med. 3:196-204.
8. Opipari, A.J., Boguski, M.S., and Dixit, V.M. 1990. The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J. Biol. Chem. 265:14705-14708.
9. Opipari, A.J., Hu, H.M., Yabkowitz, R., and Dixit, V.M. 1992. The A20 zinc finger protein protects cells from TNF cytotoxicity. J. Biol. Chem. 267:12424-12427.
10. Ferran, C., and Stroka, D.M. 1997. Adenovirus-mediated gene transfer of A20 renders endothelial cells resistant to activation: a means of evaluating the role of EC activation in xenograft rejection. Transplant Proc. 29:879-880.
11. Cooper, J.T., et al. 1996. A20 blocks endothelial cell activation through a NF-κB-dependent mechanism. J. Biol. Chem. 271:18068-18073.
12. LeBrun, D.P., Warnke, R.A., and Cleary, M.L. 1993. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am. J. Pathol. 142:743-753.
13. Lu, Q.L., Poulsom, R., Wong, L., and Hanby, A.M. 1993. Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J. Pathol. 169:431-437.
14. Reed, J.C. 1994. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1-6.
15. Boise, L.H., et al. 1993. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:597-608.
16. Oltvai, Z.N., Milliman, C.L., and Korsmeyer, S.J. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619.
17. Sedlak, T.W., et al. 1995. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA. 92:7834-7838.
18. Wang, H.G., Takayama, S., Rapp, U.R., and Reed, J.C. 1996. Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. USA. 93:7063-7068.
19. White, E. 1996. Life, death, and the pursuit of apoptosis [review]. Genes Dev. 10:1-15.
20. Vanhaesebroek, B., et al. 1993. Effect of bcl-2 proto-oncogene on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity. Oncogene. 8:1075-1081.
21. Hennet, T., Bertoni, G., Richter, C., and Peterhans, E. 1993. Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. Cancer Res. 53:1456-1460.
22. Pober, J.S., et al. 1986. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J. Immunol. 136:1680-1687.
23. Cotran, R.S., Gimbrone, M.A., Jr., Bevilacqua, M.P., Mendrick, D.L., and Pober, J.S. 1986. Induction and detection of a human endothelial activation antigen in vivo. J. Exp. Med. 164:661-666.
24. Gimbrone, M.J., Cotran, R.S., and Folkman, J. 1974. Human vascular endothelial cells in culture. Growth and DNA synthesis. J. Cell Biol. 60:673-684.
25. Brostjan, C., et al. 1996. Deletion analysis of the porcine E-selectin promoter. Transplant Proc. 28:649-651.
26. de Martin, R., et al. 1993. Cytokine-inducible expression in endothelial cells of an IκBα-like gene is regulated by NF-κB. EMBO J. 12:2773-2779.
27. Bilbao, G., et al. 1999. Genetic cytoprotection of human endothelial cells during the preservation time with an adenoviral vector encoding the anti-apoptotic human Bcl-2 gene. Transplant Proc. In press.
28. Graham, F.L., and Prevec, L. 1991. Manipulation of adenovirus vectors. In Methods in molecular biology: gene transfer and expression protocols. 7th ed. E.J. Murray, editor. Press Inc. Clifton, NJ. 109-128.
29. McGrory, W.J., Bautista, D.S., and Graham, F.L. 1988. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology. 163:614-617.
30. Bett, A.J., Prevec, L., and Graham, F.L. 1993. Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol. 67:5911-5921.
31. Kerr, J.F., Wyllie, A.H., and Currie, A.R. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics [review]. Br. J. Cancer. 26:239-257.
32. McCarthy, J.V., Ni, J., and Dixit, V.M. 1998. RIP2 is a novel NF-κB-activating and cell death-inducing kinase. J. Biol. Chem. 273:16968-16975.
33. Karsan, A., Yee, E., and Harlan, J.M. 1996. Endothelial cell death induced by tumor necrosis factor a is inhibited by the Bcl-2 family member A1. J. Biol. Chem. 271:27201-27204.
34. Pober, J.S., and Cotran, R.S. 1990. Cytokines and endothelial cell biology. Physiol. Rev. 70:427-451.
35. Collins, T., Palmer, H.J., Whitley, M.Z., Neish, A.S., and Williams, A.J. 1993. A common theme in endothelial cell activation: insights from the structural analysis of the genes for E-selectin and VCAM-1. Trends Card. Med. 3:92-97.
36. Ferran, C., et al. 1995. Inhibition of NF-κB by pyrrolidine dithiocarbamate blocks endothelial cell activation. Biochem. Biophys. Res. Commun. 214:212-223.
37. Grimm, S., Bauer, M.K.A., Bauerle, P.A., and Schultze-Osthoff, K. 1996. Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J. Cell. Biol. 134:13-23.
38. Wrighton, C.J., et al. 1996. Inhibition of endothelial cell activation by adenovirus-mediated expression of IκBα, an inhibitor of the transcription factor NF-κB. J. Exp. Med. 183:1013-1022.
39. Zimmermann, K., et al. 1991. trans-activation of the HIV-1 LTR by the HIV-1 Tat and HTLV-I Tax proteins is mediated by different cis-acting sequences. Virology. 182:874-878.
40. Collins, T. 1993. Biology of disease - endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab. Invest. 68:499-508.
41. Laine, J., Etelamaki, P., Holmberg, C., and Dunkel, L. 1997. Apoptotic cell death in human chronic allograft rejection. Transplantation. 63:101-105.
42. Thompson, C. 1995. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456-1462.
43. Abello, P.A., Fidler, S.A., Bulkley, G.B., and Buchman, T.G. 1994. Antioxidants modulate induction of programmed endothelial cell death (apoptosis) by endotoxin. Arch. Surg. 129:134-140.
44. Buchman, T.G., Abello, P.A., Smith, E.H., and Bulkley, G.B. 1993. Induction of heat shock response leads to apoptosis in endothelial cells previously exposed to endotoxin. Am. J. Physiol. 265:165-170.
45. Araki, S., Ishida, T., Yamamoto, T., Kaji, K., and Hayashi, H. 1993. Induction of apoptosis by hemorrhagic snake venom in vascular endothelial cells. Biochem. Biophys. Res. Commun. 190:148-153.
46. Re, F., et al. 1994. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J. Cell Biol. 127:537-546.
47. Robaye, B., Mosselmans, R., Fiers, W., Dumont, J.E., and Galand, P. 1991. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am. J. Pathol. 138:447-453.
48. Chinnayian, A.M., O'Rourke, K., Tewari, M., and Dixit, V. 1995. FADD, a novel death domain-containing protein interacts with the death domain of Fas and initiates apoptosis. Cell. 81:505-512.
49. Hsu, H., Xiong, J., and Goeddel, D.V. 1995. The TNF-receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell. 81:495-504.
50. Hsu, H., Shu, H.B., Pan, M.G., and Goeddel, D.V. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:299-308.
51. Pohlman, T.H., and Harlan, J.M. 1989. Human endothelial cell response to lipopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis. Cell. Immunol. 119:41-52.
52. Polunovsky, V.A., Wendt, C.H., Ingbar, D.H., Peterson, M.S., and Bitterman, P.B. 1994. Induction of endothelial cell apoptosis by TNF-α: modulation by inhibitors of protein synthesis. Exp. Cell Res. 214:584-594.
53. Kondo, S., et al. bcl-2 gene prevents apoptosis of basic fibroblast growth factor-deprived murine aortic endothelial cells. Exp. Cell Res. 213:428-32.
54. Kaszubska, W., et al. 1993. Cyclic AMP-independent ATF family members interact with NF-κB and function in activation of the E-selectin promoter in response to cytokines. Mol. Cell. Biol. 13:7180-7190.
55. DeLuca, L.G., Johnson, D., Whitley, M., Collins, T., and Pober, J. 1994. cAMP and tumor necrosis factor competitively regulate transcriptional activation through and nuclear factor binding to the cAMP-responsive element/activating transcription factor element of the endothelial leukocyte adhesion molecule-1 (E-selectin) promoter. J. Biol. Chem. 269:19193-19196.
56. Stein, B., and Baldwin, A.S.J. 1993. Distinct mechanisms for regulation of the Interleukin-8 gene involve synergism and cooperatively between C/EBP and NF-κB. Mol. Cell. Biol. 13:7191-7198.
57. Lin, K., et al. 1995. Thiol agents Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappaB. J. Cell Biol. 131:1149-1161.
58. Ivanov, V.N., Deng, G., Podack, E.R., and Malek, T.R. 1995. Pleiotropic effects of Bcl-2 on transcription factors in T cells - potential role of NF-kappa-B P50-P50 for the anti-apoptotic function of Bcl-2. Int. Immunol. 7:1709-1720.
59. Allbrecht, H., Tschopp, J., and Jongeneel, V. 1994. Bcl-2 protects from oxidative damage and apoptotic cell death without interfering with activation of NF-κB by TNF. FEBS Lett. 351:45-48.
60. Jäättela, M., Benedict, M., Tewari, M., Shayman, J.A., and Dixit, V.M. 1995. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene. 10:2297-305.
61. Linette, G.P., Li, Y., Roth, K., and Korsmeyer, S.J. 1996. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc. Natl. Acad. Sci. USA. 93:9545-9552.
62. Dbaibo, G.S., et al. 1997. Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-α: CrmA and Bcl-2 target distinct components in the apoptotic pathway. J. Exp. Med. 185:481-490.
63. Mandal, M., et al. 1996. Bcl-2 prevents CD95 (Fas/APO-1)-induced degradation of lamin B and poly (ADP-ribose) polymerase and restores the NF-κB signaling pathway. J. Biol. Chem. 271:30354-30359.
64. Hockenbery, D.M., Oltvai, Z.N., Yin, X.M., Milliman, C.L., and Korsmeyer, S.J. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:241-251.
65. Chinnaiyan, A.M., et al. 1996. Molecular ordering of the cell death pathway. J. Biol. Chem. 271:4573-4576.
66. Traenckner, E.B.M., and Baeuerle, P.A. 1995. Appearance of apparently ubiquitin-conjugated IκB-α during its phosphorylation-induced degradation in intact cells. J. Cell Sci. Suppl. 19:79-84.
67. Traenckner, E.B.M., et al. 1995. Phosphorylarion of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14:2876-2883.
68. Traenckner, E.B.M., Wilk, S., and Bauerle, P. 1994. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylation form of IκBα that is still bound to NF-κB. EMBO J. 13:5433-5441.
69. White, D.W., and Gilmore, T.D. 1996. Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of IκB-α in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins. Oncogene. 13:891-899.
70. Schreck, R., Meier, B., Mannel, D.N., Droge, W., and Baeuerle, P.A. 1992. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med. 175:1181-1194.
71. Chen, C.Y., and Faller, D.V. 1996. Phosphorylation of Bcl-2 protein and association with p21Ras in Ras-induced apoptosis. J. Biol. Chem. 271:2376-2379.
72. Fernandez-Sarabia, M., and Bischoff, J.R. 1993. Bcl-2 associates with the ras-related protein R-ras p23. Nature. 366:274-275.
73. Wang, H.G., et al. 1994. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene. 9:2751-2756.
74. Shibasaki, F., Kondo, E., Akagi, T., and McKeon, F. 1997. Suppression of signalling through transcription factor NF-AT interactions between calcineurin and Bcl-2. Nature. 386:728-731.
75. Wang, H.G., Rapp, U.R., and Reed, J.C. 1996. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell. 87:629-638.
76. Hambleton, J., McMahon, M., and DeFranco, A.L. 1995. Activation of Raf-1 and mitogen-activated protein kinase in murine macrophages partially mimics lipopolysaccharide-induced signaling events. J. Exp. Med. 182:147-54.
77. Jelinek, T., Dent, P., Stutgill, T.W., and Weber, M.J. 1996. Ras-induced activation of RAF-1 is dependent on tyrosine phosphorylation. Mol. Cell. Biol. 16:1027-1034.
78. Li, S.F., and Sedivy, J.M. 1993. Raf-1 protein kinase activates the NF-κB transcription factor by dissociating the cytoplasmic NF-κB-IκB complex. Proc. Natl. Acad. Sci. USA. 90:9247-9251.
79. Chirillo, P., et al. 1996. Hepatitis B virus Px activates NF-κB-dependent transcription through a Raf-independent pathway. J. Virol. 70:641-646.
80. Zha, J., Harada, H., Yang, E., Jockel, J., and Korsmeyer, S.J. 1996. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL. Cell. 87:619-628.
81. Sato, T., et al. 1994. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA. 91:9238-9242.
82. L. Nature. 379:554-556.
83. Hunter, J.J., Bond, B.L., and Parslow, T.G. 1996. Functional dissection of the human Bcl-2 protein: sequence requirements for inhibition of apoptosis. Mol. Cell. Biol. 16:877-883.
84. Yin, D.X., and Schimke, R.T. 1996. Inhibition of apoptosis by overexpressing Bcl-2 enhances gene amplification by a mechanism independent of aphidicolin pretreatment. Proc. Natl. Acad. Sci. USA. 93:3394-3398.
85. Yin, X.M., Oltvai, Z.N, and Korsmeyer, S.J. 1994. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature. 369:321-323.
86. Bach, F.H., Winkler, H., Ferran, C., Hancock, W.W., and Robson, S.C. 1996. Delayed xenograft rejection. Immunol. Today. 17:379-383.